- Home
- WINT vs CNEY Comparison
WINT vs CNEY Comparison
Compare WINT & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WINT
- CNEY
- Stock Information
- Founded
- WINT 1992
- CNEY 2018
- Country
- WINT United States
- CNEY China
- Employees
- WINT N/A
- CNEY N/A
- Industry
- WINT Biotechnology: Biological Products (No Diagnostic Substances)
- CNEY Major Chemicals
- Sector
- WINT Health Care
- CNEY Industrials
- Exchange
- WINT Nasdaq
- CNEY Nasdaq
- Market Cap
- WINT 2.2M
- CNEY 2.1M
- IPO Year
- WINT 1995
- CNEY 2021
- Fundamental
- Price
- WINT $0.49
- CNEY $2.76
- Analyst Decision
- WINT Hold
- CNEY
- Analyst Count
- WINT 1
- CNEY 0
- Target Price
- WINT $350.00
- CNEY N/A
- AVG Volume (30 Days)
- WINT 7.2M
- CNEY 53.7K
- Earning Date
- WINT 08-18-2025
- CNEY 01-01-0001
- Dividend Yield
- WINT N/A
- CNEY N/A
- EPS Growth
- WINT N/A
- CNEY N/A
- EPS
- WINT N/A
- CNEY N/A
- Revenue
- WINT N/A
- CNEY $50,957,974.00
- Revenue This Year
- WINT N/A
- CNEY N/A
- Revenue Next Year
- WINT N/A
- CNEY N/A
- P/E Ratio
- WINT N/A
- CNEY N/A
- Revenue Growth
- WINT N/A
- CNEY N/A
- 52 Week Low
- WINT $0.36
- CNEY $2.53
- 52 Week High
- WINT $737.44
- CNEY $40.00
- Technical
- Relative Strength Index (RSI)
- WINT 35.91
- CNEY 44.63
- Support Level
- WINT $0.52
- CNEY $2.58
- Resistance Level
- WINT $0.64
- CNEY $2.87
- Average True Range (ATR)
- WINT 0.09
- CNEY 0.18
- MACD
- WINT -0.00
- CNEY 0.03
- Stochastic Oscillator
- WINT 14.12
- CNEY 41.82
About WINT Windtree Therapeutics Inc.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
About CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.